Regeneron Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
REGN Nasdaq 8731 http://www.regeneron.com/ 412.50 Stock Up +8.38

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Regeneron Pharmaceuticals Inc

3:00 am Regeneron Pharma and Sanofi (SNY) receives FDA acceptance for Priority Review by FDA for Dupilumab Biologics License Application; PDUFA target action date of March 29, 2017 - Sep 26th, 2016 7:00 am